Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 9

1.

Increased concentrations of tirofiban in blood and their correlation with inhibition of platelet aggregation after greater bolus doses of tirofiban.

Schneider DJ, Herrmann HC, Lakkis N, Aguirre F, Lo MW, Yin KC, Aggarwal A, Kabbani SS, DiBattiste PM.

Am J Cardiol. 2003 Feb 1;91(3):334-6. No abstract available.

PMID:
12565092
2.

[Use of thrombocyte aggregation inhibitors in cardiology].

Schmidt BM, Wehling M.

Internist (Berl). 1997 Dec;38(12):1242-5. Review. German. No abstract available.

PMID:
9465333
3.

Current strategies with high-dose tirofiban.

Mukherjee D, Roffi M.

Expert Opin Drug Metab Toxicol. 2007 Apr;3(2):275-80. Review.

PMID:
17428156
4.

Tirofiban and emergency coronary surgery.

Shanmugam G.

Eur J Cardiothorac Surg. 2005 Oct;28(4):546-50. Review.

PMID:
16126403
5.

Optimizing platelet P2Y12 inhibition for patients undergoing PCI.

Steinhubl S, Roe MT.

Cardiovasc Drug Rev. 2007 Summer;25(2):188-203. Review. Erratum in: Cardiovasc Drug Rev. 2007 Autumn;25(3):299.

PMID:
17614940
6.

Clinical pharmacology of inhibitors of platelet aggregation.

Fuccella LM.

Pharmacol Res Commun. 1979 Nov;11(10):825-52. Review. No abstract available.

PMID:
395541
7.

[Inhibition of thrombocyte aggregation as a therapeutic principle. Review of the literature and currently approved thrombocyte aggregation inhibitors].

Huber K, Andreesen R.

Internist (Berl). 2000 Apr;41 Suppl 1:S34-9. Review. German. No abstract available.

PMID:
10840662
8.

Role of anticoagulation and anti-aggregation.

Strano A, Davì G, Di Giorgi C.

Eur Heart J. 1986 Dec;7 Suppl C:93-8. Review. No abstract available.

PMID:
3545841
9.

[Results of a multicenter study with Lipostabil].

Hevelke G, Högn T, Haase W, Böhlau V.

Med Welt. 1980 Apr 18;31(16):598-602. Review. German. No abstract available.

PMID:
6993837

Supplemental Content

Support Center